Table 2.
Ethanol Intake (g/kg) for Each of the mGlu Receptor Compound Tests (mean ± SEM)
MPEP Dose (μg) | |||||
---|---|---|---|---|---|
Region | 0 | 1 | 3 | 10 | 30 |
Nucleus Accumbens | .74 ± .14 | .87 ± .19 | .55 ± .10 | .24 ± .12a | |
Dorsomedial Caudate | 1.17 ± .17 | 1.22 ± .20 | 1.22 ± .16 | 1.01 ± .25 | |
Medial Prefrontal Cortex | .83 ± .09 | .80 ± .16 | .53 ± .24 | .71 ± .14 | .67 ± .14 |
LY379268 (μg) | |||||
0 | .03 | .1 | .17 | ||
Nucleus Accumbens | 1.10 ± .23 | .62 ± .11 | .60 ± .22 | .25 ± .11a |
mGlu, metabotropic glutamate; MPEP, 2-methyl-6-(phenylethynyl)pyridine hydrochloride.
p < .05 relative to 0 (Dunnett).